ScinoPharm Taiwan, Ltd. (TPE:1789)
Taiwan · Delayed Price · Currency is TWD 23.95
+0.30 (1.27%)
Jan 13, 2026, 10:05 AM CST
ScinoPharm Taiwan Market Cap
ScinoPharm Taiwan has a market cap or net worth of 18.7 billion as of January 12, 2026. Its market cap has increased by 7.99% in one year.
Market Cap
18.70B
Enterprise Value
16.63B
Revenue
3.19B
Ranking
n/a
PE Ratio
98.46
Stock Price
23.95
Market Cap Chart
Since October 29, 2010, ScinoPharm Taiwan's market cap has decreased from 30.44B to 18.70B, a decrease of -38.56%. That is a compound annual growth rate of -3.15%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jan 12, 2026 | 18.70B | 41.19% |
| Dec 31, 2025 | 13.24B | -24.04% |
| Dec 31, 2024 | 17.44B | -16.48% |
| Dec 29, 2023 | 20.88B | 3.73% |
| Dec 30, 2022 | 20.12B | 3.25% |
| Dec 30, 2021 | 19.49B | -14.56% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Caliway Biopharmaceuticals | 228.62B |
| PharmaEssentia | 189.36B |
| Lotus Pharmaceutical | 76.92B |
| Bora Pharmaceuticals Co., LTD. | 64.12B |
| Heron Neutron Medical | 59.70B |
| Oneness Biotech | 33.15B |
| Lumosa Therapeutics | 31.67B |
| Center Laboratories | 30.53B |